UHS - uhsinc.com Prognoz qilingan narxning foydaga nisbati

uhsinc.com (UHS) tovar belgisi

Universal Health Services (UHS) kompaniyasining foyda ko'rsatkichi (P/E) dinamikasi psixiatriya va shifoxona sektorlarini rivojlantirish orqali diversifikatsiyaning ta'sirini aks ettiradi, bunda ushbu ko'rsatkich hozirda 8.50 darajasida turibdi. Biznes samaradorligi xarajatlarni minimallashtirish uchun farmatsevtika mahsulotlarini tejamkor holda xarid qilishga tayanadi, yetakchi sarf materiallari yetkazib beruvchilari bilan tuzilgan uzoq muddatli shartnomalar esa klinikalarning uzluksiz faoliyatini ta'minlaydi.

uhsinc.com - UHS Forvard P/E multiplikatori (davr: 04.07.2022 - 12.11.2026)

Universal Health Services Corp (UHS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:Universal Health Services, Inc.
uhsinc.com brendining mahsuloti

Universal Health Services (UHS) klinikalari tarmog'ining yetukligi va psixiatrik yordamning muhim ahamiyati biznes barqarorligini ta'minlaydi. Universal Health Services (UHS) kompaniyasining forward P/E ko'rsatkichi Fed'ning qat'iy siyosati sharoitida bozorning foyda kutib qolishlarini aks ettiradi. Ushbu metrika joriy aksiya narxining prognoz qilingan aksiya uchun foyda nisbati sifatida hisoblanadi. Ushbu ko'rsatkichning pasayishi aktivning qadrsizlanganligini yoki foyda kamayishi xavfini anglatishi mumkin. Biznesning fundamental kuchini aniqlash uchun investorlarning ushbu tendentsiyani baholashi muhimdir.

Universal Health Services (UHS) raqobatchilari

Kelajakdagi narxning foydaga nisbati HCA Healthcare, Inc. (HCA)|Tenet Healthcare Corp - Narxning kelajakdagi foydaga nisbati|Fresenius Medical Care Corp - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati SOLV (Solventum Health)|EHC: Prognoz qilingan narxning foydaga nisbati|DVA - Forvard P/E multiplikatori|RadNet (RDNT) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati OPCH|SGRY (Surgery Partners Corp) - Forvard P/E multiplikatori|Premier Health (PINC) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati EYE (National Vision Holdings)|Kelajakdagi narxning foydaga nisbati PGNY (progyny.com)|Forvard P/E multiplikatori ARDT (Ardent Health Partners)|Select Medical Corporation (SEM) - Prognoz qilingan narx-foyda nisbati|ASTH - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori MD (Pediatrix Medical)|usph.com (USPH) - Kelajakdagi narxning foydaga nisbati|PNTG - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|ORGO (Organogenesis) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nutex Health Inc|Kelajakdagi narxning foydaga nisbati Auna Health (AUNA)|Kelajakdagi narxning foydaga nisbati SBC (SBC Medical Group Inc)|Evolus, Inc. - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CYH|Beauty Health - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori MDWD (MediWound Ltd.)|BTMD: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati The Joint (JYNT)|DCGO (DocGo Inc.) - Forvard P/E multiplikatori|Forvard P/E multiplikatori P3 Health|Kelajakdagi narxning foydaga nisbati Gain Therapeutics (GANX)|Kelajakdagi narxning foydaga nisbati EUDA (EUDA Health Holdings)|Basel Medical Group Ltd - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati CLGN (CollPlant)|Cuprina Holdings (Cayman) Ltd - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori CCM (concordmedical.com)|AMS (American Shared Hospital Services) - Prognoz qilingan narxning foydaga nisbati|MEDIROM Healthcare Group Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Avalon GloboCare Corp|DIH Group (DHAI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori XAGE|NIVF - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati ATI Physical Therapy, Inc. ATIP|Kelajakdagi narx-foyda multiplikatori CMAX|KDLY: Prognoz qilingan narxning foydaga nisbati|MODV: Kelajakdagi narxning foydaga nisbati|NVOS: Forvard P/E multiplikatori|SSY - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|BACK (IMAC Holdings) - Forvard P/E multiplikatori